GNTA
Price
$0.87
Change
-$0.01 (-1.14%)
Updated
Feb 4 closing price
Capitalization
20.45M
Intraday BUY SELL Signals
MREO
Price
$0.41
Change
-$0.01 (-2.38%)
Updated
Feb 4 closing price
Capitalization
66.52M
55 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GNTA vs MREO

Header iconGNTA vs MREO Comparison
Open Charts GNTA vs MREOBanner chart's image
Genenta Science SpA
Price$0.87
Change-$0.01 (-1.14%)
Volume$190.71K
Capitalization20.45M
Mereo BioPharma Group
Price$0.41
Change-$0.01 (-2.38%)
Volume$4.74M
Capitalization66.52M
GNTA vs MREO Comparison Chart in %
GNTA
Daily Signal:
Gain/Loss:
MREO
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
GNTA vs. MREO commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNTA is a Hold and MREO is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (GNTA: $0.87 vs. MREO: $0.41)
Brand notoriety: GNTA and MREO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GNTA: 14% vs. MREO: 24%
Market capitalization -- GNTA: $20.45M vs. MREO: $66.52M
GNTA [@Biotechnology] is valued at $20.45M. MREO’s [@Biotechnology] market capitalization is $66.52M. The market cap for tickers in the [@Biotechnology] industry ranges from $119.38B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GNTA’s FA Score shows that 1 FA rating(s) are green whileMREO’s FA Score has 1 green FA rating(s).

  • GNTA’s FA Score: 1 green, 4 red.
  • MREO’s FA Score: 1 green, 4 red.
According to our system of comparison, MREO is a better buy in the long-term than GNTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GNTA’s TA Score shows that 3 TA indicator(s) are bullish while MREO’s TA Score has 5 bullish TA indicator(s).

  • GNTA’s TA Score: 3 bullish, 3 bearish.
  • MREO’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, MREO is a better buy in the short-term than GNTA.

Price Growth

GNTA (@Biotechnology) experienced а -35.36% price change this week, while MREO (@Biotechnology) price change was -8.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.81%. For the same industry, the average monthly price growth was +0.47%, and the average quarterly price growth was +32.90%.

Reported Earning Dates

MREO is expected to report earnings on Apr 01, 2026.

Industries' Descriptions

@Biotechnology (-3.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MREO($66.5M) has a higher market cap than GNTA($20.4M). MREO YTD gains are higher at: -1.608 vs. GNTA (-41.436).
GNTAMREOGNTA / MREO
Capitalization20.4M66.5M31%
EBITDAN/A-40.14M-
Gain YTD-41.436-1.6082,577%
P/E RatioN/AN/A-
RevenueN/A500K-
Total CashN/A48.7M-
Total DebtN/A397K-
FUNDAMENTALS RATINGS
MREO: Fundamental Ratings
MREO
OUTLOOK RATING
1..100
76
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
96
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
47

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GNTAMREO
RSI
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
89%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
77%
MACD
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
N/A
Bullish Trend 23 days ago
81%
Declines
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
85%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 7 days ago
86%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
GNTA
Daily Signal:
Gain/Loss:
MREO
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MCLE0.03N/A
+19.23%
MEDICALE CORP.
BIOVF37.00N/A
N/A
Swedish Orphan Biovitrum AB
GSHRF0.79-0.01
-1.13%
GOLD X2 MINING INC.
WLWHY3.44-0.18
-4.92%
Woolworths Holdings Ltd.
NMTAY0.47-0.04
-7.94%
Neometals Ltd.

GNTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, GNTA has been closely correlated with VTGN. These tickers have moved in lockstep 83% of the time. This A.I.-generated data suggests there is a high statistical probability that if GNTA jumps, then VTGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNTA
1D Price
Change %
GNTA100%
-1.27%
VTGN - GNTA
83%
Closely correlated
-3.20%
QNCX - GNTA
83%
Closely correlated
+9.28%
CALC - GNTA
78%
Closely correlated
+8.37%
MREO - GNTA
77%
Closely correlated
-2.73%
TPST - GNTA
75%
Closely correlated
-1.24%
More

MREO and

Correlation & Price change

A.I.dvisor indicates that over the last year, MREO has been closely correlated with VTGN. These tickers have moved in lockstep 87% of the time. This A.I.-generated data suggests there is a high statistical probability that if MREO jumps, then VTGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MREO
1D Price
Change %
MREO100%
-2.73%
VTGN - MREO
87%
Closely correlated
-3.20%
RZLT - MREO
82%
Closely correlated
-7.62%
CALC - MREO
80%
Closely correlated
+8.37%
BCAB - MREO
80%
Closely correlated
+11.06%
GNTA - MREO
77%
Closely correlated
-1.27%
More